Categories Cannabis, Earnings

Organigram (NASDAQ: OGI) Q1 2020 Earnings Snapshot

— Organigram Holdings Inc. (NASDAQ: OGI) reported a net loss from continuing operations of $9 million for the first quarter of 2020, vs. a profit of $29.5 million last year.

— Loss per share was $0.006, compared to earnings per share of $0.195 per share in the year-ago period

— First-quarter net revenues more than doubled to $25.15 million from $12.44 million last year

— Gross margin, before fair value changes to biological assets and inventories, rose to $9.3 million from $8.8 million a year earlier

— Adjusted EBITDA was $4.9 million during the three-month period, compared to $6.8 million in the first quarter of 2019

— Expects to start shipping Edison + Feather ready-to-go distillate pens before the end of January 2020

— Plans to launch cannabis-infused dissolvable powder product in the second quarter of calendar 2020

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips

Most Popular

WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable retail environment. These factors have put pressure on the drugstore

Main points from Accenture’s (ACN) Q3 2024 earnings report

Shares of Accenture (NYSE: ACN) rose 6% on Thursday, following the company’s announcement of its third-quarter 2024 earnings results. Although revenue and profits missed expectations, the stock jumped after the

ACB Earnings: Aurora Cannabis reports narrower Q4 loss on higher revenues

Aurora Cannabis, Inc. (NASDAQ: ACB) on Thursday reported a net loss for the fourth quarter of 2024. The company’s revenues moved up 5% year-over-year during the quarter. The Canada-based recreational

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top